- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03702010
Spinal Cord Stimulation in Patients With Post-Laminectomy Syndrome in Testing Phase
Randomized, Single-blind, Multicenter, Crossover, Controlled Clinical Trial to Compare Difference on the Visual Analogue Scale With Two Modes of Spinal Cord Stimulation in Patients With Post-Laminectomy Syndrome in Testing Phase
Traditionally, pain relief through spinal cord stimulation has been associated with the appearance of paresthesia in the affected area. Several parameters are set to maximize the overexposure zone, such as frequency,and pulse width. Although this technique has improved pain in many patients, paresthesia itself can be uncomfortable. Traditionally, the occurrence of paresthesias has been considered to be a predictor of success in pain elimination, while the non-occurrence of paresthesias would indicate failure. So far, few studies have reported pain relief below the threshold of onset of paresthesia. Some clinical trials for pathologies other than the one considered in this study have achieved relief below the threshold by reducing the amplitude of the stimulus. Recently, however, it has been observed in a pilot study that, by increasing the frequency of spinal cord stimulation to 1 kilohertz, it is possible to significantly improve pain relief compared to less frequent conventional stimulation based on the occurrence of paresthesias.
A recent review by the Cochrane Library concluded that conventional spinal cord stimulation for pain relief of Failed Back Surgery Syndrome (or FBSS) requires further clinical studies and better designs to demonstrate its superiority over other therapeutic options. Therefore, although spinal cord stimulation is accepted by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), new techniques are being introduced that offer better results in terms of pain relief. Among these techniques, there is the high frequency mode, which allows avoiding the annoying sensation of paresthesia that substitutes pain with the conventional technique. In order to provide greater rigour and scientific quality, the present study is proposed, in which the conventional spinal cord stimulation (CME) technique (control branch or CME) is compared with paresthesias and a standard frequency (60 hertz) with a high frequency (1000 hertz) EVOLVE system (Evolve workflow - standardized guidance to simplify the trial and implant experience and optimize patient outcomes) (experimental branch or EME) by means of a design with a high degree of scientific evidence, randomising the global sample of patients to each of the two branches of stimulation in the study (blind to the patient) and crossing the branches after a period of washing
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Salamanca, Spain, 37007
- Complejo Asistencial Universitario de Salamanca
-
-
La Rioja
-
Logroño, La Rioja, Spain, 26006
- Hospital San Pedro de Logroño
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 18 years of age.
- Patients with FBSS syndrome with leg pain or leg and back pain.
- Get a score on the visual analogue scale (VAS) ≥ 7.
- Have received medical pharmacological treatment for at least 6 months after back surgery.
- The patient has signed the informed consent form.
Exclusion Criteria:
- Patients under 18 years of age.
- Patients who require a diathermic energy source (microwave, ultrasound or short wave).
- Patients with a pacemaker.
- Patients carrying a defibrillator.
- Patient with a cochlear implant.
- Patients with other active implanted devices.
- Patients who are scheduled to have any of the following procedures during the study period: an MRI, defibrillation or cardioversion, electrocautery, lithotripsy, radiofrequency or microwave ablation, and any other high-frequency ultrasound procedure,
- Women of childbearing age who do not use adequate contraception.
- Pregnant or breastfeeding.
- Participation in another trial.
- Patients who have expressed a desire not to participate in the study and have not formed informed consent.
- Patients with a failed spinal cord stimulation implant previously
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: CME branch
In this study, the conventional spinal cord stimulation method (control Branch-CME branch)
|
If the patient has been assigned to the branch of the CME control group, after mapping the search for the pain zone, the neurostimulator is programmed to conventional stimulation.
Other Names:
|
EXPERIMENTAL: EME branch
In this study, the experimental spinal cord stimulation method are used in the same patient with the EVOLVE programming guide (EME branch)
|
If the patient has been randomized to the branch of the EME experimental group, after a mapping of the search for the pain zone, a 90% subthreshold stimulation is programmed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparing Visual Analogue Scale (VAS)
Time Frame: Baseline, After first stimulation (5days), after washout and second stimulation (12 days), After 30-day follow-up (42 days)
|
Visual analogue scale (VAS) at the end of each test phase (either with conventional spinal cord stimulation or with EVOLVE). VAS consists of a 10 centimeter (cm) line, whose ends are defined as the extreme limits of pain (left end corresponds with the absence of pain and the right end with the maximum amount of pain). The patient is asked to point out in the line the place that better correspond to his/her pain, ranging from 0 to 10. |
Baseline, After first stimulation (5days), after washout and second stimulation (12 days), After 30-day follow-up (42 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change (%) in VAS Scale at the End of Treatment.
Time Frame: After first stimulation (Five days after baseline), After second stimulation (12 days after baseline), at the end of follow-up (42 days after baseline)
|
Change (%) in Visual Analogue Scale (VAS) at the end of treatment.
Please note that positive values indicate a decrease in the VAS scale, which would indicate pain relief, as it was calculated as the value at the earlier time point minus the value at the later time point. |
After first stimulation (Five days after baseline), After second stimulation (12 days after baseline), at the end of follow-up (42 days after baseline)
|
Evaluation Disability
Time Frame: Baseline, After first stimulation (+5 days), After washout and second stimulation (+12 days), at the end of follow-up (+42days)
|
Oswestry Disability Index of the patients: it is a questionnaire consisting of 10 questions with 6 possible answers each. Every answer gives a punctuation from 0 (less disability) to 5 (more disability). This scale is expressed in percentage in which 0 percentage (%) would the least disability and 100 percentage (%) would represent the maximum disability. |
Baseline, After first stimulation (+5 days), After washout and second stimulation (+12 days), at the end of follow-up (+42days)
|
Number of Participants With Adverse Events in Each Arm
Time Frame: 42 days from baseline
|
Considering as an adverse event those that result in death, or in severe harm to patient's health (lesion that threatens life, permanent harm on an organ or corporal function, or process that needs a medical or surgical intervention to avoid permanent harm)
|
42 days from baseline
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Francisco J Sánchez-Montero, MD, IBSAL-Instituto de Investigación Biomédica de Salamanca
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Central Nervous System Diseases
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Wounds and Injuries
- Disease
- Musculoskeletal Diseases
- Trauma, Nervous System
- Spinal Cord Diseases
- Bone Diseases
- Back Pain
- Syndrome
- Postoperative Complications
- Spinal Diseases
- Spinal Cord Injuries
- Failed Back Surgery Syndrome
Other Study ID Numbers
- EST-MED-2018-01
- E.C.P.S. 18/1398 (OTHER: IBSAL (INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Failed Back Surgery Syndrome
-
Fundación Universidad Católica de Valencia San...Instituto de Investigación Biomédica de SalamancaNot yet recruitingFailed Back Surgery SyndromeSpain
-
Assiut UniversityNot yet recruitingFailed Back Surgery Syndrome
-
Poitiers University HospitalCompleted
-
Boston Scientific CorporationTerminatedPain | Back Pain | Failed Back Surgery SyndromeUnited States, United Kingdom, Canada, France
-
Moens MaartenCompleted
-
Jaseng Hospital of Korean MedicineCompletedFailed Back Surgery SyndromeKorea, Republic of
-
MedtronicNeuroTerminatedFailed Back Surgery SyndromeFrance, Germany, Belgium, Austria, Netherlands, Australia, Switzerland, United Kingdom, Spain, Israel
-
Poitiers University HospitalCompleted
-
University of Sao PauloCompletedLow Back Pain | Failed Back Surgery SyndromeBrazil
Clinical Trials on spinal cord stimulation conventional
-
Case Western Reserve UniversityCompletedSpinal Cord Stimulation | High-frequency Stimulation | High-density StimulationUnited States
-
Barts & The London NHS TrustBoston Scientific CorporationUnknown
-
Seoul National UniversityTerminatedPain, IntractableKorea, Republic of
-
University of British ColumbiaProvidence Health & Services; International Spinal Research Trust; International...RecruitingSexual Dysfunction, Physiological | Spinal Cord Injuries | Neurogenic Bowel | Neurogenic Bladder | Spinal Cord StimulationCanada
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruiting
-
Universitair Ziekenhuis BrusselMedtronicCompletedFailed Back Surgery SyndromeBelgium
-
James J. Peters Veterans Affairs Medical CenterRecruitingOrthostatic HypotensionUnited States
-
Imperial College LondonRecruitingParkinson Disease | Freezing of GaitUnited Kingdom
-
University of Sao Paulo General HospitalActive, not recruitingParkinson Disease | Gait Disorders, NeurologicBrazil
-
University of CalgaryInternational Collaboration on Repair DiscoveriesUnknownSpinal Cord Injuries | Autonomic Dysreflexia | Orthostatic Hypotension, DysautonomicCanada